A. Definitions
- Refers to syndromes characterized:
- MORE by symptoms, suffering, and disability
- THAN by disease-specific, demonstrable abnormalities of structure or function
- Variations on behavioral disorders, usually with environmental stimulus
- Characteristics of patients with FSS
- Very explicit disease attributions for their symptoms
- Resist information that contradicts these assertions
- Sense of assertiveness and embattled advocacy with respect to disease etiology
- Often devalue or dismiss medical, scientific, and epidemiologic evidence which conflicts with their beliefs
- Patients are commonly refractory to treatment of symptoms (versus "underlying" cause)
- Complicating Factors
- Many of these syndromes have significant political and social standing
- Legal and compensation issues are often prominent
- Unclear if these are distinct syndromes, or if there is one or very few underlying cause(s) [3]
B. Characteristics
- Syndrome usually includes:
- Headache, musculoskeletal pain, fatigue
- Gastrointestinal distress
- Concentration and memory difficulties
- Sleep problems
- symptoms are diffuse, nonspecific,
- symptoms reported occur in healthy populations at about same rate as in syndrome
- FSS may co-occur with psychiatric conditions
- FSS may be a subconscious reaction to stress
- Diagnoses of exclusion
- Possible Etiologies
- Heightened perception of body sensation and/or
- Unidentified group of neurotransmitter or hormonal disorders in which levels are normal but response is exaggerated
C. Syndromes Classified as FSS
- Multiple chemical sensitivity
- Sick building syndrome
- Repetition stress injury
- Chronic whiplash
- Chronic Lyme Disease / Lyme Syndrome [4]
- Silicone Breast Implant Side Effects
- Candidiasis Hypersensitivity
- Gulf War Syndrome
- Food allergies
- Mitral valve prolapse (MVP) symptom complex
- Hypoglycemia
- Possible FSS
- These conditions share phenomenologic and psychosocial characteristics of FSS
- Chronic Fatigue Syndrome (CFS)
- Fibromyalgia (FM)
- Irritable Bowel Syndrome (IBS)
D. Psychosocial Attributes of FSS and Patients
- Discrepancy between scientific knowledge about FSS and public perception of FSS
- Patients may perceive themselves as victims by of putative FSS causal factor
- Quasi-scientific books published by lay press often imply "conspiracy" to suppress evidence about FSS
- Patients quickly assume "sick role"
- Patients become aggressive self-advocates, particularly when clinicians are skeptical
E. Historical and Epidemiological Perspective
- Conditions comprised of somatic symptoms typical of an FSS have arisen for at least last 300 years
- Outbreaks begin with small number of cases among individuals in physical proximity to one another - work, school, military units
- Epidemiological analysis suggests infectious agent, transmission often later found to occur along lines of interpersonal communication
- Potential disease source may include infection, mechanical injury, chemical exposure
- Prevalence rates vary from one population to another, even when exposure is equivalent
- No dose response curve can be firmly established
- Historically, incidence increased until medical community found no infectious agent, pathogenic toxin, or physical vector which caused the condition
- When no cause could be established, the incidence declined
- Examples:
- Neurasthenia
- Chronic brucellosis
- Railway spine
- Soldier's heart
- Pattern of falling incidence after medical community reaches conclusion has changed in 20th century
- Patients are more informed and assertive medical consumers
- Patients increasingly question healthcare professional's judgment and motives
- Characteristics of FSS, above, describe the attributes of syndrome in 20th century
F. Evaluating the Patient
- Rule out presence of diagnosable medical disorders
- Limit testing and referrals for consults with specialists
- Testing exposes patients to iatrogenic risk
- Testing and consults confirm patient perception of having a serious medical problem
- This fosters sick role
- Negative test results provide little assurance, because patients feel ill
- Rule out psychiatric disorders, especially:
- Anxiety
- Panic disorders
- Major depression
- Likelihood of a psychiatric disorder increases linearly with number of somatic complaints the patient reports
- Patients reporting pain at 2 sites have 5X prevalence of major depression
- Patients reporting pain at 3 or more sites have 8X prevalence of major depression
- If psychiatric disorder detected, emphasize relationship between body pain and psychiatric condition as one of "amplification"
- Biochemical derangement in brain alters physical sensations as well as mood
- Symptoms of FSS may improve with pharmaceutical treatment of psychiatric disorder.
- Build collaborative relationship with patient
G. Building A Collaborative and Trusting Relationship
- Physician must make effort to acknowledge and legitimize patient's suffering despite ack of definitive biomedical explanation
- Make restoration of daily functions the treatment goal
- Patients should be encouraged to do as much as they can
- This is because the activity itself will have therapeutic value
- Avoid making the goal a "cure", because this will be very long and difficult
- Prescribe exercise - use prescription pad to write out, augment with handout
- Prescribe strict to adherence to basic sleep hygiene program - write prescription and augment with handout
- Prescribe return to work
- Return to work should be gradual only if patient requires slower transition
- Delay prescription use here so that patient is not intimidated
- However, eventually written prescription to return to work may be helpful
- Provide limited reassurance
- "You're fine" will not help FSS patients, because they don't feel fine
- The patient's suffering and disability must be acknowledged
- Support the patient's sense of self-efficacy
References
- Henningsen P, Zipfel S, Herzog W. 2007. Lancet. 369(9565):946
- Barsky AJ and Borus JF. 1999. Ann Intern Med. 130(11):911
- Wessely S, Nimnuan C, Sharpe M. 1999. Lancet. 354(9182):936
- Feder HM Jr, Johnston BJ, O'Connell S, et al. 2007. NEJM. 357(14):1422